Isolation and characterization of a novel TP53-inducible gene, TP53TG5, which suppresses growth and shows cell cycle-dependent transition of expression

Genes Chromosomes and Cancer

Volumn 27, Issue 4, 2000, Pages 345-352

  Isaka, Shigeyuki ^a   Takei, Yoshiki ^b   Tokino, Takashi ^c   Koyama, Kumiko ^a,b,d   Miyoshi, Yasuo ^a   Suzuki, Mikio ^e   Takahashi, Eiichi ^e   Azuma, Chihiro ^a   Murata, Yuji ^a   Nakamura, Yusuke ^a,b  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c SAPPORO MEDICAL UNIVERSITY   (Japan)

^d CANCER CHEMOTHERAPY CENTER   (Japan)

^e OTSUKA PHARMACEUTICAL CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; DNA; GENE PRODUCT; GREEN FLUORESCENT PROTEIN;

ARTICLE; CELL CYCLE; CELLULAR DISTRIBUTION; CHROMOSOME 20Q; COLONY FORMATION; CONTROLLED STUDY; DNA SEQUENCE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE; GENE EXPRESSION; GENE ISOLATION; GROWTH; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; MOLECULAR CLONING; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

AMINO ACID SEQUENCE; ANTINEOPLASTIC AGENTS; CELL CYCLE PROTEINS; CHROMOSOMES, HUMAN, PAIR 20; CLONING, MOLECULAR; DNA-BINDING PROTEINS; FEMALE; GENE EXPRESSION REGULATION; GENES, P53; GROWTH INHIBITORS; HUMANS; MALE; MICROSCOPY, FLUORESCENCE; MOLECULAR SEQUENCE DATA; TUMOR CELLS, CULTURED;

EID: 0034048774     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2264(200004)27:4<345::AID-GCC2>3.0.CO;2-3     Document Type: Article

References (24)

1. Bench AJ, Aldred MA, Humphray SJ, Champion KM, Gilbert JG, Asimakopoulos FA, Deloukas P, Gwilliam R, Bentley DR, Green AR. 1998. A detailed physical and transcriptional map of the region of chromosome 20 that is deleted in myeloproliferative disorders and refinement of the common deleted region. Genoimics 149:351-362.
2. Bouffler SD, Kemp CJ, Balmain A, Cox R. 1995. Spontaneous and ionizing radiation-induced chromosomal abnormalities in p53-deficient mice. Cancer Res 55:3883-3889.
3. Dameron KM, Yolpert OV, Tainsky MA, Bouck N. 1994. Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1. Science 265:1582-1584.
4. El-Deiry WS, Kern SE, Pietenpol JA, Kinzler KW, Vogelstein B. 1992. Definition of a consensus binding site for p53. Nat Genet 1:45-49.
5. El-Deiry WS, Tokino T, Velculeseu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B. 1993. WAF-1. a potential mediator of p53 tumor suppression. Cell 75:817-825.
6. Furuhata T, Tokino T, Urano T, Nakamura V. 1996. Isolation of a novel GPI-anchored gene specifically regulated by p53: correlation between its expression and anti-cancer drug sensitivity. Oncogene 13:1965-1970.
7. Gossen M, Bujard H. 1992. Tight control of gene expression on mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci USA 89:5547-5551.
8. Man H-J, Tokino T, Nakamura Y. 1998. CSR, a scavenger receptor-like protein with a protective role against cellular damage caused by UV irradiation and oxidative stress. Hum Mol Genet 6:1039-1046.
9. Hirst WJ, Czepulkowski B, Mufti GJ. 1993. Consistent interstitial chromosomal deletions in myeloid malignancies and their correlation with fragile sites. Cancer Genet Cytogenet 65:51-57.
10. Hollstein M, Sidransky D, Vogelstein B, Harris CC. 1991. p53 mutations in human cancers. Science 253:49-53.
11. Kastan MB, Zhan Q, El-Deiry WS, Carrier F, Jacks T, Walsh WV, Plunkett BS, Vogelstein B, Fornace AJ Jr 1992. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell 71:587-597.
12. Ko LJ, Prives C. 1996. p53: puzzle and paradigm. Genes Dev 10:1054-1072.
13. Levine AJ. 1997. p53, cellular gatekeeper for growth and division. Cell 88:323-331.
14. Lichter P, Ledbetter SA, Ledbettet DH, Ward DC. 1990. Fluorescence in situ hybridization with Alu and L1 polymerase reaction probes for rapid characterization of human chromosomes in hybrid cell lines. Proc Natl Sci USA 87:6634-6638.
15. Lowe SW, Ruley HE, Jacks T, Housman DE. 1993. p53-dependent apoptosis modulates the cytotoxicity of anti cancer agents. Cell 74:957-967.
16. Mercer WE, Shields MT, Amin M, Sauve GJ, Appella E, Romano JW, Ullrich SJ. 1990. Negative growth regulation in a glioblastoma tumor cell line that conditionally expresses human wild-type p53. Proc Natl Acad Sci USA 87:6166-6170.
17. Miyashita T, Reed JC. 1995. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80:293-299.
18. Ng CC, Koyama K, Okamura S, Kondoh H, Takei Y, Nakamura Y. 1999. Isolation and characterization of a novel TP53-inducible gene, TP53TG3. Gene Chromosomes Cancer 26:329-335.
19. Nishimori H, Shiratsuchi T, Urano T, Kimura Y, Kiyono K, Tatsumi K, Yoshida S, Ono M, Kuwano M, Nakamura Y, Tokino T. 1997. A novel brain-specific p53-target gene, BAI1. containing thrombo-spondin type 1 repeats inhibits experimental angiogenesis. Oncogene 15:2145-2150.
20. Takahashi E, Hori T, O'Connell P, Leppert M, White R. 1990. R-banding and nonisotopic in situ hybridization: precise localization of the human type collagen gene (COL2A1). Hum Genet 86:14-16.
21. Takahashi E, Yamauchi M, Tsuji H, Hitomi A, Meuth M, Hori T. 1991. Chromosome mapping of the human cytidine-5′-triphosphate (CTPS) gene to band 1p34.1-p34.3 by fluorescence in situ hybridization. Hum Genet 88:119-121.
22. Takei Y, Ishikawa S, Tokino T, Muto T, Nakamura Y. 1998. Isolation of a novel TP53 target gene from a colon cancer cell line carrying a highly regulated wild-type TP53 expression system. Genes Chromosomes Cancer 23:1-9.
23. Tokino T, Thiagalingam S, El-Deiry WS, Waldman T, Kinzler KW, Vogelstein B. 1994. p53 tagged sites from human genomic DNA. Hum Mol Genet 3:1537-1542.
24. Urano T, Nishimori H, Han H, Furuhata T, Kimura Y, Nakamura Y, Tokino T. 1997. Cloning of P2XM, a novel human P2X receptor gene regulated by p53. Cancer Res 57:3281-3287.